Journals / Çocuk Dergisi / 2011 / Cilt: 11 - Sayı: 2

Anaphylaxis and Advances in Anaphylaxis

Anafilaksi ve Anafilaksideki Gelişmeler

Pages
43–53
Publication Date
2011-04-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

On discharge from hospital, an autoinjectible epinephrine should be prescribed and appropriate should be providd about its use In this review pathogenesis, clini- cal features, diagnosis and new treatment modalities of anaphylaxis were presented

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Anaphylaxis is a serious hypersensitivity reaction with a rapid onset which might eventually lead to death.
📊
Key Findings & Data:The incidence anaph- ylaxis is increasing, particularly during the first 2 decades of life.
💡
Conclusion & Impact:On discharge from hospital, an autoinjectible epinephrine should be prescribed and appropriate should be providd about its use In this review pathogenesis, clini- cal features, diagnosis and new treatment modalities of anaphylaxis were presented
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Anafilaksi · tanı · tedavi

Abstract

Anaphylaxis is a serious hypersensitivity reaction with a rapid onset which might eventually lead to death. Anaphylaxis is a clinical emergency. The incidence anaph- ylaxis is increasing, particularly during the first 2 decades of life. Common triggers include foods, medications, and insect stings. Its diagnosis is based primarily on clinical criteria. In some patients the clinical diagnosis of anaph- ylaxis can be confirmed by means of a blood test i.e., an increased plasma histamine or serum total tryptase level . However, these tests are not specific for anaphylaxis. Adrenaline is the first choice medication in the treatment of anaphylaxis. On discharge from hospital, an autoinjectible epinephrine should be prescribed and appropriate should be providd about its use In this review pathogenesis, clini- cal features, diagnosis and new treatment modalities of anaphylaxis were presented

Özet

Anafilaksi, ani başlayan ve ölüme yol açabilen ciddi siste- mik bir hipersensitivite reaksiyonudur. Anafilaksi klinik bir acildir. Anafilaksi insidansı özellikle yaşamın ilk iki deka- dında artmaktadır. Yaygın olan tetikleyiciler besinler, ilaç- lar ve böcek sokmalarıdır. Tanısı primer olarak klinik kri- terlere dayanır. Bazı hastalarda anafilaksi tanısı kan test- leri artmış histamin ve total triptaz düzeyi gibi ile doğru- lanabilir. Fakat bu testler anafilaksi için spesifik değildir. Adrenalin anafilaksi tedavisinde ilk seçenek ilaçtır. Hastalar taburcu edilirken adrenalin otoenjektörü reçete edilmeli ve kullanımının eğitimi verilmelidir. Bu makalede anafilaksinin patogenezi, kliniği, tanı ve yeni tedavi yön- temleri sunulmuştur

🔖

Cite This Article

BOSTANCI, İ., DOĞRU, M. (2011). Anaphylaxis and Advances in Anaphylaxis. Çocuk Dergisi, Cilt: 11 - Sayı: 2, 43–53. https://ajindex.com/articles/247003

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Portier MM, Richet C. De l’action anaphylactique de certains venims. Comptes Rendus des Seances Mem Soc Biol 1902;54:170-2
  2. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: Report of the nomenclature review committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113:832-6. http://dx.doi.org/10.1016/j.jaci.2003.12.591 PMid:15131563 3. Simons FE. Anaphylaxis. J Allergy Clin Immunol 2010;125(2 Suppl 2):161-81. http://dx.doi.org/10.1016/j.jaci.2009.12.981 PMid:20176258 4. Lieberman P, Camargo CA Jr, Bohlke K, Jick H, Miller RL, Sheikh A, et al. Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 2006;97:596-602.
  3. Decker WW, Campbell RL, Manivannan V, Luke A, St Sauver JL, Weaver A, et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J Allergy Clin Immunol 2008;122:1161-5. http://dx.doi.org/10.1016/j.jaci.2008.09.043 PMid:18992928 PMCid:2704497 6. Shen Y, Li L, Grant J, Rubio A, Zhao Z, Zhang X, et al. Anaphylactic deaths in Maryland (US) and Shanghai: a review of forensic autopsy cases from 2004 to 2006. Forensic Sci Int 2009;186:1-5. http://dx.doi.org/10.1016/j.forsciint.2008.12.007 PMid:19217731 7. Yocum MW, Butterfield JH, Klein JS, Volcheck GW, Schroeder DR, Silverstein MD. Epidemiology of anaphylaxis in Olmsted County: a population-based study. J Allergy Clin Immunol 1999;104:452-6.
  4. Lin RY, Anderson AS, Shah SN, Nurruzzaman F. Increasing anaphylaxis hospitalization in the first two decades of life: New York State, 1990-2006. Ann Allergy Asthma Immunol 2008;101:387-93.
  5. Simons FE. Anaphylaxis: Recent advances in assessment and treatment. J Allergy Clin Immunol 2009;124(4):625-36. http://dx.doi.org/10.1016/j.jaci.2009.08.025 PMid:19815109 10. Moneret-Vautrin DA, Morisset M, Flabbee J, Beaudouin E, Kanny G. Epidemiology of life threatening and lethal anaphylaxis: a review. Allergy 2005;60:443-51. http://dx.doi.org/10.1111/j.1398-9995.2005.00785.x PMid:15727574 11. Pumphrey RS. Fatal anaphylaxis in the UK, 1992–2001. Novartis Found Symp 2004;257:116-28.
  6. Yilmaz R, Yuksekbas